Margaret Davy - Concepedia

Author

Margaret Davy

Also Known As

C. Dalrymple, Jim Nicklin, M Davy, M L Davy, M. Davy, M. L. J. Davy, M.L.J. Davy, MARGARET DAVY, MARGARET L. J. DAVY, Margaret DAVY

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Royal Adelaide Hospital Norwegian Cancer Society South Australia Pathology The University of Adelaide Royal Women's Hospital

About

Margaret Davy is an author at Royal Adelaide Hospital specializing in medicine, obstetrics, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	612
2	Public Health	4	4	226
3	Health Sciences	2	2	53
4	Cell Biology	2	2	59
5	Cellular Therapies	1	1	21

Margaret Davy

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Luen Bik To, Marion M. Roberts, David N. Haylock, PubMed	1992	414
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer Beth Y. Karlan, Amit M. Oza, Gary Richardson, Journal of Clinical Oncology	2011	225
Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA Geoffrey D. Higgins, Diana M. Uzelin, Gael E. Phillips, The Lancet Human Papillomavirus RnaPrecancerous LesionsCervical CancerCervical HealthHuman Papillomavirus Vaccines	1991	143
The morbidity of surgery and adjuvant radiotherapy in the management of endometrial carcinoma David Nunns, Karin Williamson, Linda Swaney, International Journal of Gynecological Cancer	2000	91
Prognostic Importance of Preoperative CA-125 in International Federation of Gynecology and Obstetrics Stage I Epithelial Ovarian Cancer: An Australian Multicenter Study Sellva Paramasivam, Lee Tripcony, Alex J. Crandon, Journal of Clinical Oncology	2005	81
Cervical cancer: effect of glandular cell type on prognosis, treatment, and survival Margaret Davy Obstetrics and Gynecology	2003	69
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: Data from CALYPSO trial (a GINECO-GCIG study) Benoît You, Olivier Colomban, M. Heywood, Gynecologic Oncology Ca 125MedicineGynecologyStrong Prognostic ValueCancer Treatment	2013	68
Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix Jens Overgaard, Søren M. Bentzen, Per Kolstad, International Journal of Radiation OncologyBiologyPhysics Gynecological SurgeryCervical CancerMedicineGynecologyUterine Cervix	1989	59
A study of 656 patients with “early” ovarian cancer David Guthrie, Margaret Davy, P. R. Philips Gynecologic Oncology Gynecological SurgeryMedicineGynecologyOncologyGynecology Oncology	1984	54
Serous carcinoma of the uterus—determination of HER-2/neu status using immunohistochemistry, chromogenic in situ hybridization, and quantitative polymerase chain reaction techniques: its significance and clinical correlation Pritanjali Singh, Chad Smith, Glenice Cheetham, International Journal of Gynecological Cancer	2008	51

Page 1